Neurodermatitis
RecruitingICP-332 for Adults with Prurigo Nodularis
ICP-332 for Adults with Prurigo Nodularis
- Disease:Neurodermatitis
- Substances:–
Poland- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Ul. Cypriana Kamila Norwida 3, 80-280 Gdansk, Poland
Akk Medical Sp. z o.o. in Gdansk, Poland specialises in clinical trials of conditions such as Neurodermatitis, Dermatitis atopic, Hidradenitis, Psoriasis, and other specialisations. This site conducts important research.
At Akk Medical Sp. z o.o. in Gdansk, clinical trials in immune system diseases are focused on improving care for people with chronic inflammatory skin conditions. The research is centered on testing new therapies and assessing how well they reduce symptoms such as itching and inflammation.
This work reflects a strong interest in better symptom control, treatment effectiveness, and safety for patients living with persistent immune-mediated disorders.
Clinical research at this site also covers skin and connective tissue diseases, with a particular focus on conditions that can significantly affect comfort, appearance, and quality of life. The trials are designed to evaluate new medicines and compare them with placebo to see whether they improve visible skin changes and patient-reported symptoms.
Across these studies, investigators are looking at treatment effectiveness and patient outcomes, helping advance options for chronic dermatologic conditions at the Centrum Medyczne Tu Się Leczy.
Clinical trials currently enrolling participants at this site.
ICP-332 for Adults with Prurigo Nodularis
PolandLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
PolandStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
PolandStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
PolandStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
PolandStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
PolandStudy on the Effects and Safety of Piclidenoson for Patients with Moderate-to-Severe Plaque Psoriasis
PolandStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.